2011

December 2011

• "Reference Standards: Regulatory requirements" 
• Christopher A, Bravery, PhD. 
• Informa Life Sciences 2nd Annual: Cell Therapy Manufacturing: Stem Cells and Immunotherapies.  
• Chair, speaker, panel discussion, workshop.
• Brussels, Belgium

 

November 2011

•  "Regulatory requirements for early stage clinical trials with cell-based medicinal products" 
• Christopher A, Bravery, PhD. 
• World Conference on Regenerative Medicine
• Leipzig, Germany
• Speaker

• Joint DIA/MHRA Workshop on Advanced Therapy Medicinal Products
• Christopher A, Bravery, PhD. 
• London, UK
• Chair, panel discussion

October 2011

• "Regulatory issues to watch for during tech transfer between sites"  
• Christopher A, Bravery, PhD.
• IBC's Inaugural Cell Therapy Bioprocessing
• Virginia, United States.
• Speaker

• "Regulating Cell Therapy: An Ex-regulators perspective"  
• Christopher A, Bravery, PhD.
• Seminar, ESRC Innogen Centre
• Edinburgh, Scotland
• Speaker

 

June 2011

• "A Review of the Global Clinical and Commercial Activity in Cell and Gene Therapies"  
• Christopher A, Bravery, PhD.
• PDA 2011 Europe Workshop on Advanced Therapy Medicinal Products.
• Helsinki, Finland
• Speaker

 

May 2011

• "The EU Risk-Based Approach: What Does it Mean?"  
• Christopher A, Bravery, PhD.
• International Society for Cellular Therapy: ICT 2011 Annual Meeting.
• Rotterdam, The Netherlands.

 

April 2011

• "What's happened since Regulation 1394/2007?"  
• Christopher A, Bravery, PhD.
• Regenerative Medicine in Europe (REMEDIE): Bringing Regenerative Medicine to the Clinic: Trials and Tribulations in Europe and Beyond.
• Bilbao, Vizcaya, Spain.

 

March 2011

• http://www.celltherapysociety.org/index.php/meetings-events/webinars/isct-webinars#march16 
• Christopher A, Bravery, PhD.
• Webinal: Potency testing.
• London, United Kingdom.

• Seminar
• Christopher A, Bravery, PhD.
• EUCRAF: Particulars of authorisation of biopharmaceuticals.
• Freiburg, Germany.

• "Common Regulatory Issues for Stem Cell Products" 
• Christopher A, Bravery, PhD.
• UKNSCN Fourth Annual Science Meeting.
• York, United Kingdom.

 

January 2011 

• Workshop on progress towwards Clinical Trials using stem cells for ALS/MND
• Christopher A, Bravery, PhD.
• International Consortium of Stem Cell Networks (ICSCN).
• New York, United States